Table 3.
Oxaliplatin alone (n = 67) | Oxaliplatin + bevacizumab (n = 10) | P-value | |
---|---|---|---|
Group 1 (SOS grade 0, n = 35), n | 7 | 4 | 0.003 |
Group 2 (SOS grade 1, n = 49), n | 23 | 5 | |
Group 3 (SOS grade 2, n = 51), n | 28 | 1 | |
Group 4 (SOS grade 3, n = 16), n | 9 | 0 |